BAX and ovarian cancer: The same results were reported for the combination ofluteolin (50 and 100 μM) and cisplatin (2 μg/mL), whereindemonstrating synergistic modulation of Bax and Bcl-2 in ovarian cancer.6 Programmed cell death-related genes p53 and p27were upregulated significantly by a combination of chrysin (25 μM)and docetaxel (2.5 ng/mL) in comparison to individual treatment inNSCLC.46